Xingwen Wang

2.2k total citations · 1 hit paper
53 papers, 1.7k citations indexed

About

Xingwen Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xingwen Wang has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 21 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xingwen Wang's work include Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (13 papers) and RNA Research and Splicing (6 papers). Xingwen Wang is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (13 papers) and RNA Research and Splicing (6 papers). Xingwen Wang collaborates with scholars based in China, United Kingdom and United States. Xingwen Wang's co-authors include Ying Hu, Dong Zhao, Shanliang Zheng, Kunming Zhao, Qingyu Lin, Hao Liu, Xuting Xue, Chun Mao, Mimi Wan and Wenjie Ge and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Xingwen Wang

52 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications

2022 175 citations Shanliang Zheng, Xingwen Wang et al. Trends in Cell Biology profile →

Peers

Countries citing papers authored by Xingwen Wang

Since Specialization

Citations

This map shows the geographic impact of Xingwen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingwen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingwen Wang more than expected).

Fields of papers citing papers by Xingwen Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingwen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingwen Wang. The network helps show where Xingwen Wang may publish in the future.

Co-authorship network of co-authors of Xingwen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xingwen Wang. A scholar is included among the top collaborators of Xingwen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingwen Wang. Xingwen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase Separation: A New Dimension to Understanding Tumor Biology and Therapy 2025 ·SHILAP Revista de lepidopterología ·Xingwen Wang, (unknown), (unknown), Jiangwen Ma, Ying Hu	0
2	A previously uncharacterized role of TAp73 in ferroptosis by modulating oxidative homeostasis in cervical cancer 2025 ·Cancer Letters ·Yafan Gong, (unknown), Xingwen Wang, Shanliang Zheng, Hao Liu, Qingyu Lin, Meiqi Wang, Jiangwen Ma, (unknown), (unknown), Ying Hu	1
3	ER-associated degradation ligase HRD1 links ER stress to DNA damage repair by modulating the activity of DNA-PKcs 2024 ·Proceedings of the National Academy of Sciences ·(unknown), Guixue Hou, Shanliang Zheng, (unknown), (unknown), Qingyu Lin, Hao Liu, Xingwen Wang, (unknown), Yuhan Wei, (unknown), Yi Zhang, Chaoran Liu, (unknown), Qun‐Ying Lei, Ying Hu	4
4	Unraveling Key m⁶A Modification Regulators Signatures in Postmenopausal Osteoporosis through Bioinformatics and Experimental Verification 2024 ·Orthopaedic Surgery ·(unknown), (unknown), Xingwen Wang, (unknown), Dacheng Zhao, (unknown), Shenghong Wang, Bo Peng, Fei Yang, Bin Geng, Minggang Guo, (unknown), Yayi Xia	5
5	A novel lncRNA GM15416 regulates osteoblast apoptosis and differentiation through the c-Fos/Fas axis and mitigates osteoporosis 2023 ·International Journal of Biological Macromolecules ·Dacheng Zhao, (unknown), (unknown), (unknown), Zhiwei Feng, Xingwen Wang, (unknown), Shenghong Wang, Bin Geng, Yayi Xia	7
6	Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity 2023 ·Journal of Clinical Investigation ·Qingyu Lin, Tong Liu, Xingwen Wang, Guixue Hou, (unknown), Wenxin Zhang, Shanliang Zheng, Dong Zhao, Qibin Leng, Xiaoshi Zhang, (unknown), (unknown), Hao Liu, Ying Hu	23
7	A comprehensive review on Schisandrin and its pharmacological features 2023 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Xiaohu Wang, Xingwen Wang, Hui Yao, (unknown), (unknown), (unknown)	13
8	SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation 2023 ·Molecular Cell ·(unknown), (unknown), Guixue Hou, Hao Liu, Shanliang Zheng, Xingwen Wang, Qingyu Lin, Yi Zhang, (unknown), Yafan Gong, (unknown), Yan Yu, Ying Hu	57
9	lncRNA HITT inhibits metastasis by attenuating Rab5-mediated endocytosis in lung adenocarcinoma 2022 ·Molecular Therapy ·Xingwen Wang, Shanliang Zheng, Fan Yang, (unknown), Dong Zhao, Xuting Xue, Qingyu Lin, Yunfei He, Guohong Hu, Ying Hu	9
10	Bimetal-organic framework-derived nanorod-like FexNi1−x@C, P composites for electrochemical hydrogen evolution 2022 ·Journal of Alloys and Compounds ·Yue Wang, Jingrui Zhang, Xingwen Wang, Wei Meng, (unknown), (unknown), Chao Han	13
11	Mitochondria-localized lncRNA HITT inhibits fusion by attenuating formation of mitofusin-2 homotypic or heterotypic complexes 2022 ·Journal of Biological Chemistry ·Xingwen Wang, (unknown), Qingyu Lin, Kunming Zhao, (unknown), Ying Hu	4
12	lncRNA HITT Inhibits Lactate Production by Repressing PKM2 Oligomerization to Reduce Tumor Growth and Macrophage Polarization 2022 ·Research ·Kunming Zhao, Xingwen Wang, Dong Zhao, Qingyu Lin, Yi Zhang, Ying Hu	35
13	iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation 2022 ·Oncogene ·Dong Zhao, Shanliang Zheng, Xingwen Wang, Hao Liu, Kunming Zhao, Li Li, Ying Hu	11
14	iASPP suppression mediates terminal UPR and improves BRAF-inhibitor sensitivity of colon cancers 2022 ·Cell Death and Differentiation ·Shanliang Zheng, Xingwen Wang, Hao Liu, Dong Zhao, Qingyu Lin, Qinghua Jiang, (unknown), Ying Hu	10
15	Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications breakdown → 2022 ·Trends in Cell Biology ·Shanliang Zheng, Xingwen Wang, Dong Zhao, Hao Liu, Ying Hu	175
16	Nuclear iASPP determines cell fate by selectively inhibiting either p53 or NF-κB 2021 ·Cell Death Discovery ·Wenjie Ge, Yu Wang, Shanliang Zheng, Dong Zhao, Xingwen Wang, Xiaoshi Zhang, Ying Hu	5
17	Interplay of long non-coding RNAs and HIF-1α: A new dimension to understanding hypoxia-regulated tumor growth and metastasis 2020 ·Cancer Letters ·Xingwen Wang, Dong Zhao, Hui Xie, Ying Hu	36
18	HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma 2018 ·Cancer Letters ·Huayi Li, Xingwen Wang, Cheng Zhang, Yiwei Cheng, Miao Yu, Kunming Zhao, Wenjie Ge, (unknown), Yao Zhang, (unknown), Ying Hu	15
19	iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding 2017 ·Cancer Cell ·Wenjie Ge, Kunming Zhao, Xingwen Wang, Huayi Li, Miao Yu, Mengmeng He, Xuting Xue, (unknown), Cheng Zhang, Yiwei Cheng, (unknown), Ying Hu	151
20	High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer 2015 ·Tumor Biology ·Baoying Yuan, (unknown), Xingwen Wang, Dan Wang, Huiling Liu, Ling Guo, Xiang‐An Li, Junqing Han, Hong Feng	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact